CClinicalTrials.gg
CompletedNCT04143204Updated Feb 8, 2023

Nutrition and Growth in Very Preterm Infants

An observational study in Premature and Growth, sponsored by Children's Hospital of Fudan University. Completed at 1 site in China. Open to participants aged 1 Day to 18 Months. Per ClinicalTrials.gov, last updated 2023-02-08.

Sponsored by Children's Hospital of Fudan University · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
180
Ages
1 Day to 18 Months
Sex
All
01

Study summary

This study aims to explore the relation of early nutritional intake, especially oral nutrition intake, with growth and body composition among very preterm or very low birth weight infants.

Read the detailed description

As the survival of very preterm infants increases, it is important to evaluate their long-term outcomes. Nutritional intake during early life was important to the growth and development in infants, especially in preterm infants. Studies found that early nutrition exposure in preterm infants can effect scored of Griffith Mental Development Scales and body fat percentage at later life. Insulin-like growth factor-1, leptin, Ghrelin, C-Peptide are associated with fat mass in children. And accumulation of fat and insulin resistance (IR) in the early postnatal period are related to metabolism diseases in adulthood. However, previous studies on nutrition and growth or the body composition of preterm infants were mostly completed in developed countries, and no relevant data were available in China. Therefore, this study aims to establish a prospective cohort of very preterm infants to observe the effects of nutritional exposure in early life on growth and body composition in later life.

02

Conditions studied

  • Premature
  • Growth
03

In context

Lead sponsor

Children's Hospital of Fudan University is the lead sponsor of 262 studies on the registry; 92 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Day to 18 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Very preterm or very low birth weight infants in NICU

Inclusion criteria

  • infants born with a gestational age >=28 weeks and \<32 weeks and/or a birth weight >=1000g and \<1500g;
  • infants admitted to neonatal intensive care unit (NICU) of Children's hospital of Fudan University within 24h after birth.

Exclusion criteria

Exclusion Criteria:

  • major congenital anomalies or heredity metabolic diseases;
  • severe disease or abdominal surgery during hospitalization;
  • death during hospitalization or discharge without medical advice;
  • small for gestational age.
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
180 participants (actual)
Patient registry
No
Biospecimen retention
Samples without dna

Groups and cohorts

  • very preterm infants cohort

    A prospective cohort of very preterm or very low birth weight infants from birth to corrected age 18 months.

    Other: Oral nutritional intake

Interventions

  • OtherOral nutritional intake

    The exposure are oral nutritional intake and all nutritional intake during early life (28 days), and insulin-like growth factor 1, leptin, Ghrelin, and C-peptide in serum at corrected age 40 gestational weeks.

    Also known as: All nutritional intake, Insulin-like growth factor 1, Leptin, Ghrelin, C-peptide

06

What researchers measure

Primary outcomes

  1. Z-scores of weight

    Computed according to the Fenton preterm growth standards (2013)

    Time frame: at corrected age 40 gestational weeks

Secondary outcomes

  1. Z-scores of length/height

    Computed according to the Fenton preterm growth standards (2013)

    Time frame: at corrected age 40 gestational weeks

  2. Z-scores of head circumference

    Computed according to the Fenton preterm growth standards (2013)

    Time frame: at corrected age 40 gestational weeks

  3. Z-scores of weight

    Computed according to the WHO standards (2006)

    Time frame: at corrected age 6 months and 18 months

  4. Z-scores of length/height

    Computed according to the WHO standards (2006)

    Time frame: at corrected age 6 months and 18 months

  5. Z-scores of head circumference

    Computed according to the WHO standards (2006)

    Time frame: at corrected age 6 months and 18 months

  6. Percentage of infants who achieve catch-up growth

    Catch-up growth is defined as weight, length/height or head circumference equal to or above the 25th percentile for corrected age, according to the WHO standards (2006).

    Time frame: at corrected age 6 months and 18 months

  7. Body fat free mass

    assessed by air displacement plethysmography (ADP)

    Time frame: at corrected age 40 gestational weeks and 6 months

  8. Body fat mass

    assessed by air displacement plethysmography (ADP)

    Time frame: at corrected age 40 gestational weeks and 6 months

  9. Body fat proportion

    assessed by air displacement plethysmography (ADP)

    Time frame: at corrected age 40 gestational weeks and 6 months

  10. Cognitive development outcome

    It is examined by six areas of development measured by Griffith Mental Development Scales (GMDS) including locomotor, personal-social, hearing and language, eye and hand co-ordination, performance and practical reasoning. Developmental impairment is defined as a developmental quotient lying one standard deviation below the mean (\<85) and includes mild impairments (70-84) and moderate/severe impairment (\<70).

    Time frame: at corrected age 18 months

  11. Intestinal flora change

    The change of composition of intestinal flora in preterm infants. The composition of intestinal flora was test by 16s rRNA sequencing.

    Time frame: from birth to corrected age 18 months

07

Study locations

1 site
  • Children's Hospital of Fudan University
    Shanghai, Shanghai 201102, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 8, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04143204
Lead sponsor
Children's Hospital of Fudan University
Responsible party
Sponsor
First posted
Oct 29, 2019
Start date
Aug 1, 2019
Primary completion
Oct 31, 2022
Completion
Oct 31, 2022
Last update
Feb 8, 2023

Study contacts

Weili Yan, MD, PhD
principal investigator · Children's Hospital of Fudan University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion